The Vigabatrin REMS Program is required by the FDA to ensure informed risk-benefit choices prior to launching therapy, and to ensure suitable use vigabatrin while clients are treated. When vision loss will certainly occur, it is not feasible for your medical care carrier to recognize.
The most common negative effects of SABRIL in youngsters 3 to 16 years is weight gain. With serious vision loss, you might just be able to see things straight in front of you (often called tunnel vision"). You are at danger for vision loss with any type of quantity of SABRIL.
Tell your doctor if you are expecting or mean to get expecting. If vision testing can not be done, your healthcare provider may continue recommending SABRIL, however will not be able to look for any kind of vision loss. Your health care carrier might quit recommending SABRIL for you (or your youngster)if vision examinations are not done routinely.